Microbiology Susceptibility - Local Processing

The CDASHIG MS domain is used to represent data from drug susceptibility testing performed on collected biological specimens, This includes phenotypic testing (i.e., drug is added directly to a culture of organisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host organisms, including bacteria, viruses, fungi, protozoa, and parasites. Phenotypic drug susceptibility testing may involve determining susceptibility/resistance (qualitative) at a defined concentration of antibiotic or sponsor drug, or may involve determining a specific dose (quantitative) at which a drug inhibits organism growth or some other process associated with virulence (e.g., minimum inhibitory concentration, MIC). The MS domain is appropriate for both of these types of drug susceptibility tests.

The current Controlled Terminology for MSTESTCD assumes that the test may not be agent-specific but points to a broader use of the overall MSTESTCD/MSTEST as defined in the most current version of CT.

Local Processing - In this scenario, biological specimens are taken and analyzed, and the results are recorded directly on the CRF.

This example is for a COVID test. The user will need to update the questions, as appropriate.

"Form MS - Microbiology Susceptibility Local Processing [CDASH_2-1_FO_28]" Form Preview
Form MS - Microbiology Susceptibility Local Processing
MS - Local Processing
Was the test performed? No  Yes  
What was the (start) date of the (microbiology) specimen collection?
 01 Jan 2000
What was the Microbiology Susceptibility test name?
What was the Microbiology Susceptibility Test detail?
What was the result of the examination? Positive  Negative  
What is the specimen material type? Endotracheal Fluid  Swabbed Material  
What was the anatomical location where the specimen was collected? Nose  Throat  
What was the method used for the test or examination?
* Mandatory field

MS Local